Innovative Health

What Innovative Health does

Innovative Health, Inc. is an FDA-regulated specialty medical device reprocessing company focused exclusively on single-use electrophysiology (EP) and cardiology devices. Headquartered in Scottsdale, Arizona, the company collects used single-use devices from hospitals, reprocesses them through validated cleaning, inspection, testing, and sterilization protocols at its Arizona facility, and sells them back to hospital customers at approximately half the price of new devices. The product portfolio spans mapping catheters, transseptal needles, intracardiac echocardiography (ICE) catheters, steerable introducer sheaths, diagnostic EP catheters, more than 100 reusable EP cables, and, since 2022, vascular imaging catheters used in Cardiac Cath Labs.

The company's core technology centers on proprietary methods that allow it to reprocess devices that other reprocessors cannot, including the first-ever patented microlumen reprocessing technology, electronic programmable memory decryption, advanced visual inspection methodologies, and 3D mapping location-sensor performance characterization. By January 2026, Innovative Health had accumulated 50 FDA clearances — roughly one every 10 weeks for a decade — which it describes as five times the number of clearances held by all other EP reprocessors combined. This regulatory base supports exclusive reprocessing of certain transseptal needles and mapping catheters, enabling claimed per-procedure savings of 30%+ (more than $3,000 per AFib ablation) and roughly $1,000+ per-procedure savings advantage over generalist competitors.

Innovative Health operates an enterprise go-to-market combining direct field sales to hospitals and EP labs, GPO partnerships (notably AllSpire Health GPO), strategic alliances with channel partners (SxanPro, MC Healthcare, US Endovascular, Northeast Scientific, S2S Global), a co-marketing partnership with Acutus Medical, an authenticated e-commerce storefront (store.innovative-health.com), and active presence at the Heart Rhythm Society annual conference. Revenue is generated from per-unit reprocessed-device sales (pay-as-you-go unit pricing), bundled program management services including data analytics and collection optimization, and a savings-guarantee program under which the company commits to specific savings targets. Disclosed funding totals $18 million across a 2016 and 2017 round; revenue and headcount are not publicly disclosed beyond an employee range of 51–100.

Name

Innovative Health

Legal name

Innovative Health, Inc.

Website

https://innovative-health.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Innovative Health is an FDA-regulated specialty medical device reprocessor focused on cardiology and electrophysiology, serving US hospitals and EP labs by reprocessing used single-use catheters and devices at roughly half the price of new ones.

Ownership category

akta.pro rank

Product category

Medical Device Reprocessing

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Medical device reprocessing
• Electrophysiology catheters
• Cardiology reprocessing services
• FDA cleared reprocessing
• Single-use device reprocessing

Headquarters

HQ city

Scottsdale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Reprocessed Medical Device Sales: Innovative Health collects used single-use medical devices from hospitals, reprocesses them through their FDA-regulated facilities, and sells them back at approximately half the price of new devices. This is the primary revenue stream, with reprocessed devices sold directly to hospital customers who use them in EP and cardiology procedures.
2. Program Management Services: The company provides ongoing program management services to optimize hospital reprocessing programs, including data analytics, savings reviews, collection methodology optimization, and continuous program oversight. This is a service component bundled with device sales.
3. Savings Guarantee Program: Innovative Health offers a savings guarantee where they commit to specific savings targets for hospital partners. If actual savings fall short, the company writes a check for the balance, demonstrating confidence in program effectiveness.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Core offering

Innovative Health collects used single-use electrophysiology and cardiology devices from hospitals, reprocesses them at its FDA-regulated Scottsdale facility, and sells them back at approximately half the price of new devices. The company holds about 50 FDA clearances for reprocessed devices—including mapping catheters, transseptal needles, ICE catheters, introducer sheaths, diagnostic EP catheters, EP cables, and vascular imaging catheters—supported by proprietary microlumen cleaning, sensor testing, and traceability technologies. It also bundles data-driven program management services and a savings guarantee to optimize hospital reprocessing programs.

Product overview

Innovative Health is an FDA-regulated specialty reprocessing company focused entirely on cardiology and electrophysiology (EP) devices. Founded in 2015, the company offers a portfolio of reprocessed single-use medical devices including mapping catheters, transseptal needles, diagnostic ultrasound catheters (ICE), introducer sheaths, diagnostic EP catheters, EP cables, and vascular imaging catheters. The core offering is the reprocessing service where used devices are collected, cleaned, tested, sterilized, and returned at approximately half the price of new devices. Additionally, the company provides program management services, savings calculators, and environmental impact tools. With 50 FDA clearances achieved at a rate of approximately one every 10 weeks, the company can reprocess all major brands of complex EP devices including some that only Innovative Health can process. The Scottsdale, Arizona facility handles all reprocessing operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Mapping Catheters Reprocessing FDA-cleared reprocessing of complex mapping catheters used in electrophysiology procedures, including devices with micro-lumens and intricate parts that only Innovative Health is cleared to reprocess. Sold to hospitals and EP labs at approximately half the cost of new devices, reducing per-procedure device cost in AFib and other mapping procedures.
• Transseptal Needles Reprocessing FDA-cleared reprocessing of transseptal needles (BRK, BRK-1, and NRG) used to cross the atrial septum in electrophysiology procedures. Innovative Health holds the only FDA clearances for reprocessing both major brands of transseptal needles, enabling exclusive cost savings on these devices for hospital EP labs.
• Diagnostic Ultrasound Catheters (ICE) Reprocessing

Quantifiable outcome

• 30%+ reduction in device costs per EP procedure ($3,000+ savings per AFib procedure)
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• S2S GlobalminorChannel Partner/ Reseller/ Distributor · 10 December 2024Innovative Health maintains a relationship with S2S Global (acquired by Prestige AmeriTech from Premier Inc.) for medical device reprocessing services as part of creating a major diverse-owned medical sourcing company.
• MC HealthcareminorGTM or Marketing Partner · 22 July 2024Agreement to promote reprocessing and environmental benefits of medical device reprocessing to healthcare providers.
• US EndovascularminorStrategic or Co-development Partner · 1 July 2024Partnership to drive cost savings in ambulatory surgery centers (ASCs) and office-based labs (OBLs) through reprocessing programs.
• AllSpire Health GPOcoreChannel Partner/ Reseller/ Distributor · 1 November 2023Agreement with AllSpire Health GPO to support member hospitals in their medical device re-use programs. This partnership provides access to AllSpire's member hospital network through established GPO contracting relationships.
• SxanProminorStrategic or Co-development Partner · 24 May 2021Partnership to increase EP labs' financial savings beyond traditional reprocessing by optimizing device utilization and supply chain processes.
• Acutus MedicalcoreStrategic or Co-development Partner · 30 September 2019Collaboration to increase patient access to best-in-class electrophysiology care. Acutus Medical's mapping technology combined with Innovative Health's reprocessing capabilities to reduce procedure costs.
• Northeast ScientificminorChannel Partner/ Reseller/ Distributor · 15 August 2019Partnership to increase cost savings in healthcare through expanded distribution of reprocessed devices.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Stryker Sustainability Solutions: Stryker's reprocessing division is the largest single-use device reprocessor in the US, offering reprocessed devices across multiple surgical specialties. While broader in scope than Innovative Health, it competes directly in EP and cardiology reprocessing and represents the primary generalist alternative hospital procurement teams evaluate against Innovative Health.
• Medline ReNewal: Medline's ReNewal reprocessing program offers single-use device reprocessing services to hospitals, including some EP devices. As a division of Medline — one of the largest medical product distributors — it benefits from entrenched hospital relationships and competes with Innovative Health for share of reprocessing program contracts.
• ReNu Medical: ReNu Medical is a dedicated single-use medical device reprocessor focused on non-invasive devices and supplies. While its portfolio skews toward surfaces, scopes, and compression sleeves rather than complex EP catheters, it competes in the same hospital procurement conversations around reprocessing program design and savings guarantees.
• Hygia Health Services: Hygia Health Services is a single-use medical device reprocessor offering reprocessing for a range of hospital devices. It competes with Innovative Health for hospital reprocessing contracts, particularly at health systems evaluating a single partner across multiple device categories.
• Northeast Scientific: Northeast Scientific is a medical device reprocessor and Innovative Health's distribution partner (per 2019 partnership). It competes in the reprocessing services market and is the only other reprocessor referenced in Innovative Health's own materials as a channel relationship.

Broad incumbents

• SterilMed (Johnson & Johnson): SterilMed, now part of Johnson & Johnson, was one of the original single-use device reprocessors and brings J&J's deep regulatory and distribution resources. As an OEM-affiliated reprocessor, it represents both a competitor and a structural conflict of interest — J&J's EP business (Biosense Webster) competes with the OEMs whose devices Innovative Health reprocesses.
• Abbott: Abbott is a major OEM of EP devices (including the Agilis NxT Steerable Introducer, the device behind Innovative Health's 50th FDA clearance). Abbott is the structural counterparty to Innovative Health's business — its pricing, design choices, and lobbying posture directly shape the addressable reprocessing market for EP catheters and introducers.
• Boston Scientific: Boston Scientific is a leading OEM of electrophysiology and cardiology devices, including mapping catheters and ablation tools. Its pricing and product portfolio directly define the cost problem Innovative Health solves, and its newer-generation devices shape which devices can be reprocessed.
• Johnson & Johnson (Biosense Webster): Biosense Webster, J&J's EP division, is the global market leader in electrophysiology ablation catheters and mapping systems. Its installed base and pricing of single-use EP catheters (CARTO system consumables) is the single largest source of device cost that Innovative Health's reprocessing programs target.

Others

• S2S Global (Premier): S2S Global, acquired by Prestige AmeriTech from Premier Inc., is a diverse-owned medical sourcing company with which Innovative Health maintains a distribution relationship. S2S is not a direct reprocessing competitor but represents the GPO/distribution ecosystem through which hospital reprocessing contracts are increasingly procured.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/innov_health
• Facebookfacebook.com/100063512536057

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovative Health